title: Antioxidant agents help primary Raynaud's phenomenon.
authors.affiliation: Division of Internal Medicine and Rheumatology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy - cosimobruni85@gmail.com.
authors.forename: C
authors.initials: C
authors.lastname: Bruni
authors.forename: G
authors.initials: G
authors.lastname: Lepri
authors.forename: F
authors.initials: F
authors.lastname: Peruzzi
authors.forename: S
authors.initials: S
authors.lastname: Bellando-Randone
authors.forename: A
authors.initials: A
authors.lastname: Radicati
authors.forename: M
authors.initials: M
authors.lastname: Matucci-Cerinic
authors.forename: S
authors.initials: S
authors.lastname: Guiducci
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008833:Microcirculation / Q000187:drug effects*; D008875:Middle Aged; D009262:Nails / Q000098:blood supply*; D009543:Nifedipine / Q000627:therapeutic use; D011928:Raynaud Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D066253:Vascular Remodeling / Q000187:drug effects
chemical_list: D000975:Antioxidants; D002121:Calcium Channel Blockers; D009543:Nifedipine